Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy

Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy

Abstract Response to immunotherapy widely varies among cancer patients and identification of parameters associating with favourable outcome is of great interest. Here we show longitudinal monitoring of peripheral blood samples of non-small cell lung cancer (NSCLC) patients undergoing anti-PD1 therap...

Full description

Bibliographic Details
Main Authors:	Elaine Lai-Han Leung, Run-Ze Li, Xing-Xing Fan, Lily Yan Wang, Yan Wang, Zebo Jiang, Jumin Huang, Hu-Dan Pan, Yue Fan, Hongmei Xu, Feng Wang, Haopeng Rui, Piu Wong, Hermi Sumatoh, Michael Fehlings, Alessandra Nardin, Paul Gavine, Longen Zhou, Yabing Cao, Liang Liu
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-08-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-40631-0

Similar Items

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer
by: Jia-Xin Li MB, et al.
Published: (2019-12-01)

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
by: Run-Ze Li, et al.
Published: (2022-07-01)

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
by: Meng Lv, et al.
Published: (2022-06-01)

Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
by: Michael Fehlings, et al.
Published: (2019-09-01)

Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
by: Peng Ding, et al.
Published: (2023-05-01)

The Updated Status and Future Direction of Immunotherapy Targeting B7-H1/PD-1 in Osteosarcoma
by: Fan M, et al.
Published: (2021-01-01)

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
by: Liping Pei, et al.
Published: (2023-02-01)

PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
by: Xiaohui Ren, et al.
Published: (2024-04-01)

PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
by: Yingzi Zhang, et al.
Published: (2022-11-01)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
by: Xin Wang, et al.
Published: (2019-02-01)

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
by: Min Huang, et al.
Published: (2022-11-01)

Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
by: Qianqian Wang, et al.
Published: (2018-03-01)

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration
by: Lijuan Ding, et al.
Published: (2023-03-01)

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
by: Huiyu Yan, et al.
Published: (2023-10-01)

Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
by: Chengliang Sun, et al.
Published: (2022-12-01)

Clinical applications of PD-L1 bioassays for cancer immunotherapy
by: Delong Liu, et al.
Published: (2017-05-01)

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint
by: Tingxuan Gu, et al.
Published: (2023-05-01)

Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis
by: Yuanyuan Yang, et al.
Published: (2022-11-01)

Bifidobacterium breve predicts the efficacy of anti‐PD‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients
by: Honghui Zhao, et al.
Published: (2023-03-01)

The role of exosomal PD-L1 in tumor progression and immunotherapy
by: Feiting Xie, et al.
Published: (2019-10-01)

Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
by: Xianjing Chu, et al.
Published: (2023-06-01)

Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
by: Han Yao, et al.
Published: (2018-07-01)

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
by: Wenxiao Jiang, et al.
Published: (2021-09-01)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
by: Jinhua Liu, et al.
Published: (2021-09-01)

Clinical implication of PD-L2 in the prognosis assessment of HNSCC immunotherapy
by: HUANG He, JU Houyu, YANG Wenyi, YAN Ming, REN Guoxin, HU Jingzhou
Published: (2023-06-01)

Research Progress of PD-1/PD-L1 Targeted Radionuclide Molecular Probes in Tumor Immunotherapy
by: WANG Shujing, et al.
Published: (2020-01-01)

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
by: Yimin Zheng, et al.
Published: (2023-10-01)

Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
by: Xianjing Chu, et al.
Published: (2023-06-01)

Progress of Immunotherapy Mechanisms and Current Evidence of PD-1/PD-L1  Checkpoint Inhibitors for Non-small Cell Lung Cancer with Brain Metastasis
by: Jiamin SHENG, et al.
Published: (2020-11-01)

Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy
by: Chen Yan, et al.
Published: (2022-08-01)

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
by: Hao Zhang, et al.
Published: (2023-03-01)

Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
by: Daixi Ren, et al.
Published: (2020-01-01)

GABA/baclofen stabilizes PD-L1 and enhances immunotherapy of breast cancer
by: Xue Sun, et al.
Published: (2024-04-01)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
by: Junyu Long, et al.
Published: (2017-08-01)

Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharides
by: Juanhong Zhang, et al.
Published: (2023-06-01)

Beyond PD-1 Immunotherapy in Malignant Melanoma
by: Dominika Kwiatkowska, et al.
Published: (2019-03-01)

Application of PD-1 Blockade in Cancer Immunotherapy
by: Xiaomo Wu, et al.
Published: (2019-01-01)

The function and regulation of PD-L1 in immunotherapy
by: Libin Guo, et al.
Published: (2017-09-01)

Mechanism and Clinical Application of PD-1/PD-L1 Inhibitors in Immunotherapy
by: Yang Xicheng
Published: (2022-01-01)

Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
by: Laure Chardin, et al.
Published: (2021-12-01)